In the ongoing resolution of multiple claims brought against UBS for sales of Puerto Rican bonds, an arbitration panel has awarded some $9 million to an investor.
On Friday, the Financial Industry Regulatory Authority panel awarded Luiz Romero close to $8 million in compensatory damage plus interest, as well as $1 million in punitive damages plus interest.
“Respondent UBS exercised extreme recklessness and indifference to the consequences of loan recycling by failing to utilize a supervisory system which would have alerted upper management that claimant Romero and taken $8 million from his non-purpose loan account one day and redeposited the exact same amount less than two weeks later to buy securities,” the regulatory panel explained in its decision.
According to the panel, it opted to fine the wirehouse over its “intentional and willful provision of a ‘non-purpose’ loan, which was either knowingly encouraged to be ‘recycled in violation of Regulation U or provided with a reckless indifference to the consequences of the loan recycling.”
The loan, the arbitrators say, led to “additional excessive leverage, so that when there was a downturn in the market, claimants lost more money than they would have had they been suitably invested with less leverage.”
Romero bought municipal bonds and closed-end bond funds from UBS. He filed his complaint against UBS in November 2013. Several pre-hearing sessions were held in 2015, followed by 24 hearings in 2016 and 2017.
The $70 billion market for these investments collapsed in 2013 and has resulted in more than $1.5 billion in customer claims.
“Although the arbitrators awarded significantly less than the full damages claimants requested, UBS is disappointed and disagrees with the decision to award any damages,” the firm said in a statement. “Mr. Lopez was an experienced investor who made a fully informed decision to leverage his investments and concentrate his portfolio in Puerto Rico bonds and UBS Puerto Rico closed-end funds because of their long history of providing excellent.”